1.9100
+0.0700
+(3.80%)
At close: April 17 at 4:00:03 PM EDT
1.8400
-0.07
(-3.66%)
After hours: April 17 at 7:01:11 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BEN MAIMON CAROLE S Chief Executive Officer | Stock Award(Grant) | Jan 22, 2025 | 423,954 |
| CELANO MICHAEL Chief Financial Officer | Stock Award(Grant) | Jan 22, 2025 | 178,181 |
| CLAYTON RUSSELL Officer | Stock Award(Grant) | Jan 22, 2025 | 45,806 |
| FLYNN JAMES E Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 16, 2024 | -- |
| HAMILTON THOMAS EDWARD Director | Purchase | Feb 16, 2024 | 724,231 |
| SHANKAR GOPI Officer | Stock Award(Grant) | Jan 22, 2025 | 50,806 |
| THOMAS FRANK E Director | Purchase | Feb 14, 2024 | 2,000 |
| TRUITT JOSEPH E Director | Purchase | May 17, 2023 | 2,750 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
2.7100
+18.86%
TARA Protara Therapeutics, Inc.
3.9000
-2.50%
DAWN Day One Biopharmaceuticals, Inc.
6.84
+1.18%
ATYR aTyr Pharma, Inc.
3.1000
+2.65%
MDNAF Medicenna Therapeutics Corp.
0.8200
+12.33%
INZY Inozyme Pharma, Inc.
0.9195
-4.40%
COGT Cogent Biosciences, Inc.
4.3700
+2.34%
CYTK Cytokinetics, Incorporated
39.48
+0.84%
EPRX Eupraxia Pharmaceuticals Inc.
3.2900
+2.17%
SGMT Sagimet Biosciences Inc.
2.2100
+9.41%